Interaction of unsaturated fatty acids with anti-oestrogen-binding sites
- 15 April 1987
- journal article
- research article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 243 (2) , 359-364
- https://doi.org/10.1042/bj2430359
Abstract
Specific high-affinity binding sites for non-steroidal anti-oestrogens such as tamoxifen have been identified in many animal and human tissues. The function of these binding sites and the nature of their endogenous ligands are currently unknown. Our laboratory has previously reported that unsaturated fatty acids at micromolar concentrations inhibited [3H]tamoxifen binding to the anti-oestrogen-binding sites in rat liver, raising the possibility that fatty acids might represent endogenous ligands for these sites. These studies have now been extended to examine the mechanism by which fatty acids inhibit [3H]tamoxifen binding to the anti-oestrogen-binding site. Saturation analysis revealed that increasing concentrations of oleic acid progressively decreased the apparent binding affinity of these sites for [3H]tamoxifen without decreasing the total number of binding sites; however, the apparent dissociation constant did not vary linearly with the prevailing oleic acid concentration, suggesting that the inhibition of [3H]tamoxifen binding by fatty acid was not competitive in nature. Kinetic studies of [3H]tamoxifen binding showed that oleic acid did not affect the rate of association, but increased the rate of dissociation of [3H]tamoxifen from the anti-oestrogen-binding site; the latter finding would not be expected if oleic acid acted as a competitive inhibitor. Furthermore, incubation of a rat microsomal fraction with [3H]oleic acid in the absence and presence of excess non-radioactively labelled tamoxifen also failed to demonstrate direct competition between oleic acid and tamoxifen for the same binding site. It is concluded that oleic acid, and presumably other unsaturated fatty acids, do not compete for the anti-oestrogen-binding site and probably reduce its tamoxifen-binding affinity by some other mechanism, such as perturbation of the lipid environment of the binding site. The biological significance of this interaction of unsaturated fatty acids with the anti-oestrogen-binding site remains to be elucidated.This publication has 23 references indexed in Scilit:
- The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and functionPublished by Elsevier ,2003
- An Evaluation of the Role of Antiestrogen-Binding Sites in Mediating the Growth Modulatory Effects of Antiestrogens: Studies Usingt-Butylphenoxyethyl Diethylamine, a Compound Lacking Affinity for the Estrogen Receptor*Endocrinology, 1985
- Binding of oxygenated cholesterol metabolites to antiestrogen binding sites from chicken liverBiochemical and Biophysical Research Communications, 1985
- A diphenylmethane derivative selective for the anti-estrogen binding site may help define its biological roleBiochemical and Biophysical Research Communications, 1984
- AN ENDOGENOUS LIGAND FOR THE TRIPHENYLETHYLENE ANTIESTROGEN BINDING SITEEndocrinology, 1983
- Antitumor Activity of Clomiphene Analogsin Vitro: Relationship to Affinity for the Estrogen Receptor and Another High Affinity Antiestrogen-Binding SiteJournal of Clinical Endocrinology & Metabolism, 1983
- Physicochemical and genetic evidence for specific antiestrogen binding sites.Proceedings of the National Academy of Sciences, 1983
- Modulation of microsomal glucose‐6‐phosphate translocase activity by free fatty acids: Implications for lipid domain structure in microsomal membranesJournal of Cellular Physiology, 1983
- The concept of lipid domains in membranes.The Journal of cell biology, 1982
- High-affinity anti-oestrogen binding site distinct from the oestrogen receptorNature, 1980